Related Experiment Video
Updated: Jul 19, 2025

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes
Xiaohua Jiang1, Lauren A Fielding2, Hunter Davis3
1Department of Chemistry, Vanderbilt University, Nashville, TN 37240, USA.
Abstract:
Topoisomerases, common targets for anti-cancer therapeutics, are crucial enzymes for DNA replication, transcription, and many other aspects of DNA metabolism. The potential anti-cancer effects of thiosemicarbazones (TSC) and metal-TSC complexes have been demonstrated to target several biological processes, including DNA metabolism. Human topoisomerases were discovered among the molecular targets for TSCs, and metal-chelated TSCs specifically displayed significant inhibition of topoisomerase II. The processes by which metal-TSCs or TSCs inhibit topoisomerases are still being studied. In this brief review, we summarize the TSCs and metal-TSCs that inhibit various types of human topoisomerases, and we note some of the key unanswered questions regarding this interesting class of diverse compounds.
Insights
Thiosemicarbazones (TSC) and their metal complexes show anti-cancer potential by inhibiting human topoisomerases, crucial enzymes in DNA metabolism. Metal-TSC compounds notably inhibit topoisomerase II, offering a promising therapeutic avenue.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Topoisomerases are vital enzymes regulating DNA topology during replication and transcription.
- These enzymes are established targets for anti-cancer drug development.
- Thiosemicarbazones (TSC) and their metal complexes exhibit potential anti-cancer activities by interfering with DNA metabolism.
Purpose of the Study:
- To review thiosemicarbazones (TSC) and metal-TSC complexes that inhibit human topoisomerases.
- To highlight the molecular targets of TSCs within DNA metabolism.
- To identify key unanswered questions regarding the mechanism of action.
Main Methods:
- Literature review of studies on TSCs and metal-TSCs.
- Analysis of reported data on topoisomerase inhibition.
- Identification of common themes and gaps in current research.
Main Results:
- TSCs and metal-TSC complexes target human topoisomerases.
- Metal-chelated TSCs demonstrate significant inhibition of topoisomerase II.
- The precise mechanisms of inhibition are still under investigation.
Conclusions:
- TSCs and their metal complexes represent a promising class of compounds for targeting topoisomerases in cancer therapy.
- Further research is needed to elucidate the detailed mechanisms of action for these compounds.
- Understanding these mechanisms could lead to the development of more effective anti-cancer agents.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules
EDTA: Auxiliary Complexing Reagents
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...

